Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Baylor College of Medicine |
---|---|
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00769431 |
RATIONALE: Collecting feedback from patients with prostate cancer may help doctors develop better symptom management educational materials for patients.
PURPOSE: This clinical trial is evaluating symptom management educational materials for patients with prostate cancer.
Condition | Intervention |
---|---|
Prostate Cancer |
Other: educational intervention Procedure: study of socioeconomic and demographic variables |
Study Type: | Interventional |
Official Title: | FOCUS GROUP EVALUATION OF PROSTATE CANCER SYMPTOM MANAGEMENT EDUCATION MATERIALS |
Estimated Enrollment: | 30 |
Study Start Date: | May 2008 |
Primary Completion Date: | April 2009 (Final data collection date for primary outcome measure) |
OBJECTIVES:
OUTLINE: Study participants are assigned to 1 of 3 focus groups according to educational level and ethnicity (i.e., lower educational-level African-American men primarily from the Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC); lower educational-level Caucasian men from MEDVAMC, Baylor College of Medicine (BCM), or the community; or higher educational-level Caucasian men primarily from BCM or the community).
Participants review written patient educational-intervention materials on prostate cancer and provide feedback to the investigator on the content and acceptability of these materials during a 1½-2-hour focus group discussion. Feedback data are used to revise the intervention materials so that they are appropriate to the target population.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Biopsy-proven prostate cancer
Selected for participation from 1 of the following:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
United States, Texas | |
Dan L. Duncan Cancer Center at Baylor College of Medicine | |
Houston, Texas, United States, 77030 | |
Veterans Affairs Medical Center - Houston | |
Houston, Texas, United States, 77030 |
Principal Investigator: | David Latini, PhD | Baylor College of Medicine |
Responsible Party: | Dan L. Duncan Cancer Center at Baylor College of Medicine ( David Latini ) |
Study ID Numbers: | CDR0000600594, BCM-H-21622 |
Study First Received: | October 8, 2008 |
Last Updated: | May 1, 2009 |
ClinicalTrials.gov Identifier: | NCT00769431 History of Changes |
Health Authority: | United States: Federal Government |
stage I prostate cancer stage II prostate cancer |
Prostatic Diseases Genital Neoplasms, Male Urogenital Neoplasms Genital Diseases, Male Prostatic Neoplasms |
Neoplasms Neoplasms by Site Prostatic Diseases Genital Neoplasms, Male |
Urogenital Neoplasms Genital Diseases, Male Prostatic Neoplasms |